Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Lung Cancer, Nonsmall Cell
- Non -Small Cell Lung Cancer
- Non Small Cell Lung Cancer Metastatic
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03377023
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Jhanelle E. Gray, M.D. H. Lee Moffitt Cancer Center and Research Institute
Get Well Soon